{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:35:50Z","timestamp":1782963350778,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetes technology has been shown to improve glycemic control in people with type 1 diabetes (T1DM). Despite their benefits, these technologies are used less frequently by youth from lower socioeconomic backgrounds and racial minorities worldwide. This study aimed to examine the relationship between social vulnerability, disparities in diabetes technology use, and glycemic control in youth with T1DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective billing code analysis included 1,460 patients with T1DM, aged \u2264 23\u2009years old, who were seen at a large academic diabetes center in the Midwest between January 2020 and April 2022, before the expansion of insurance coverage for diabetes technology in Missouri. We analyzed data on number of visit encounters, use of a continuous glucose monitor (CGM), use of an insulin pump, area of deprivation index (ADI) score, age, sex, race, and type of insurance. A predictive multiple linear regression model was used to assess mean hemoglobin A1c (HbA1c). A negative binomial regression was used to assess diabetic ketoacidosis (DKA) occurrences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There was statistically significant lower usage of diabetes technology in Black patients, those on Medicaid, and those with higher social vulnerability (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Increased rates of DKA were associated with older age, higher HbA1c, Black racial identity, and insulin pump use. Conversely, independent insulin pump or CGM use was significantly associated with lower HbA1c levels, especially among patients from the most disadvantaged groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study highlights that independent insulin pump or CGM use can mitigate the negative impacts of social vulnerability and race on long term glycemic control in youth with type 1 diabetes, emphasizing the need for greater access to these essential technologies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12902-025-02161-2","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T10:53:19Z","timestamp":1769251999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of social vulnerability on glycemic control and diabetes technology use in youth with type 1 diabetes"],"prefix":"10.1186","volume":"26","author":[{"given":"Nicholas R.","family":"Banull","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen I.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope","family":"Shimony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Ingram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Arbel\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"issue":"23","key":"2161_CR1","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1001\/jama.2020.6940","volume":"323","author":"LM Laffel","year":"2020","unstructured":"Laffel LM, Kanapka LG, Beck RW, et al. Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: a randomized clinical trial. JAMA. 2020;323(23):2388\u201396. https:\/\/doi.org\/10.1001\/jama.2020.6940.","journal-title":"JAMA"},{"issue":"8","key":"2161_CR2","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/pedi.12221","volume":"16","author":"JC Wong","year":"2015","unstructured":"Wong JC, Dolan LM, Yang TT, Hood KK. Insulin pump use and glycemic control in adolescents with type 1 diabetes: predictors of change in method of insulin delivery across two years. Pediatr Diabetes. 2015;16(8):592\u201399. https:\/\/doi.org\/10.1111\/pedi.12221.","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"2161_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1399-5448.2008.00440.x","volume":"10","author":"E Pa\u0144kowska","year":"2009","unstructured":"Pa\u0144kowska E, B\u0142azik M, Dziechciarz P, Szypowska A, Szajewska H. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes. 2009;10(1):52\u201358. https:\/\/doi.org\/10.1111\/j.1399-5448.2008.00440.x.","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"2161_CR4","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1177\/1932296816653411","volume":"10","author":"CAJ van Beers","year":"2016","unstructured":"van Beers CAJ, Jh D. Continuous glucose monitoring: impact on hypoglycemia. J Diabetes Sci Technol. 2016;10(6):1251\u201358. https:\/\/doi.org\/10.1177\/1932296816653411.","journal-title":"J Diabetes Sci Technol"},{"issue":"11","key":"2161_CR5","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S2213-8587(16)30193-0","volume":"4","author":"CAJ van Beers","year":"2016","unstructured":"van Beers CAJ, Jh D, Kleijer SJ, et al. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. Lancet Diabetes Endocrinol. 2016;4(11):893\u2013902. https:\/\/doi.org\/10.1016\/S2213-8587(16)30193-0.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2161_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1089\/dia.2020.0338","volume":"23","author":"S Agarwal","year":"2021","unstructured":"Agarwal S, Schechter C, Gonzalez J, Long JA. Racial-ethnic disparities in diabetes technology use among young adults with type 1 diabetes. Diabetes Technol Ther. 2021;23(4):306\u201313. https:\/\/doi.org\/10.1089\/dia.2020.0338.","journal-title":"Diabetes Technol Ther"},{"key":"2161_CR7","doi-asserted-by":"publisher","unstructured":"Lee MY, Tanenbaum ML, Maahs DM, Prahalad P. Overcoming barriers to diabetes technology in youth with type 1 diabetes and public insurance: cases and call to action. Case Rep Endocrinol. 2022, 2022;9911736. https:\/\/doi.org\/10.1155\/2022\/9911736.","DOI":"10.1155\/2022\/9911736"},{"issue":"4","key":"2161_CR8","doi-asserted-by":"publisher","first-page":"e24424","DOI":"10.7759\/cureus.24424","volume":"14","author":"K Allison","year":"2022","unstructured":"Allison K, Patel D, Kaur R. Assessing multiple factors affecting minority participation in clinical trials: development of the clinical trials participation barriers Survey. Cureus. 2022;14(4):e24424. https:\/\/doi.org\/10.7759\/cureus.24424.","journal-title":"Cureus"},{"key":"2161_CR9","doi-asserted-by":"publisher","unstructured":"Tremblay ES, Bernique A, Garvey K, Astley CM. A retrospective cohort study of racial\/ethnic and socioeconomic disparities in initiation and meaningful use of Continuous glucose monitoring among youth with type 1 diabetes. J Diabetes Sci Technol. Published online July 3, 2023: 19322968231183985. https:\/\/doi.org\/10.1177\/19322968231183985.","DOI":"10.1177\/19322968231183985"},{"key":"2161_CR10","doi-asserted-by":"publisher","unstructured":"S M, O E, N N, et al. Inequities in health outcomes in children and adults with type 1 diabetes: data from the T1D exchange quality improvement collaborative. Clin Diabetes: A Publ Of The Am Diabetes Assoc. 2021;39(3). https:\/\/doi.org\/10.2337\/cd21-0028.","DOI":"10.2337\/cd21-0028"},{"issue":"12","key":"2161_CR11","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1515\/jpem-2023-0334","volume":"36","author":"D Baboun","year":"2023","unstructured":"Baboun D, Solano N, Del Toro V, Alvarez-Salvat R, Granados A, Carrillo-Iregui A. Technology use and clinical outcomes in a racial-ethnic minority cohort of children and adolescents with type 1 diabetes. J Pediatr Endocrinol Metab. 2023;36(12):1128\u201332. https:\/\/doi.org\/10.1515\/jpem-2023-0334.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"8","key":"2161_CR12","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.eprac.2021.05.001","volume":"27","author":"AM McKee","year":"2021","unstructured":"McKee AM, Al-Hammadi N, Hinyard LJ. Disparities in utilization and outcomes with continuous subcutaneous insulin infusion in young adults with type 1 diabetes. Endocr Pract. 2021;27(8):769\u201375. https:\/\/doi.org\/10.1016\/j.eprac.2021.05.001.","journal-title":"Endocr Pract"},{"issue":"11","key":"2161_CR13","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1089\/dia.2023.0320","volume":"25","author":"O Ebekozien","year":"2023","unstructured":"Ebekozien O, Mungmode A, Sanchez J, et al. Longitudinal trends in glycemic outcomes and technology use for over 48,000 people with type 1 diabetes (2016-2022) from the T1D exchange quality improvement collaborative. Diabetes Technol Ther. 2023;25(11):765\u201373. https:\/\/doi.org\/10.1089\/dia.2023.0320.","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"2161_CR14","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1177\/1932296821995810","volume":"15","author":"KL Fantasia","year":"2021","unstructured":"Fantasia KL, Wirunsawanya K, Lee C, Rizo I. Racial disparities in diabetes technology use and outcomes in type 1 diabetes in a safety-net hospital. J Diabetes Sci Technol. 2021;15(5):1010\u201317. https:\/\/doi.org\/10.1177\/1932296821995810.","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"2161_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/pedi.13139","volume":"22","author":"TH Lipman","year":"2021","unstructured":"Lipman TH, Smith JA, Patil O, Willi SM, Hawkes CP. Racial disparities in treatment and outcomes of children with type 1 diabetes. Pediatr Diabetes. 2021;22(2):241\u201348. https:\/\/doi.org\/10.1111\/pedi.13139.","journal-title":"Pediatr Diabetes"},{"key":"2161_CR16","doi-asserted-by":"publisher","unstructured":"Sm O, Sh G. Social determinants of health and structural inequities-root causes of diabetes disparities. Diabetes Care. 2021;44(1). https:\/\/doi.org\/10.2337\/dci20-0060.","DOI":"10.2337\/dci20-0060"},{"issue":"5","key":"2161_CR17","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/19322968211006476","volume":"15","author":"A Addala","year":"2021","unstructured":"Addala A, Hanes S, Naranjo D, Maahs DM, Hood KK. Provider implicit bias impacts pediatric type 1 diabetes technology recommendations in the United States: findings from the gatekeeper study. J Diabetes Sci Technol. 2021;15(5):1027\u201333. https:\/\/doi.org\/10.1177\/19322968211006476.","journal-title":"J Diabetes Sci Technol"},{"issue":"26","key":"2161_CR18","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMp1802313","volume":"378","author":"AJH Kind","year":"2018","unstructured":"Kind AJH, Buckingham WR. Making Neighborhood-disadvantage metrics accessible - the Neighborhood Atlas. N Engl J Med. 2018;378(26):2456\u201358. https:\/\/doi.org\/10.1056\/NEJMp1802313.","journal-title":"N Engl J Med"},{"issue":"32","key":"2161_CR19","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.21105\/joss.01057","volume":"3","author":"J VanderPlas","year":"2018","unstructured":"VanderPlas J, Granger B, Heer J, et al. Altair: interactive statistical visualizations for python. JOSS. 2018;3(32):1057. https:\/\/doi.org\/10.21105\/joss.01057.","journal-title":"JOSS"},{"issue":"7","key":"2161_CR20","doi-asserted-by":"publisher","first-page":"e15283","DOI":"10.1111\/dme.15283","volume":"41","author":"JH Wers\u00e4ll","year":"2024","unstructured":"Wers\u00e4ll JH, Ekelund J, \u00c5kesson K, et al. Relative poverty is associated with increased risk of diabetic ketoacidosis at onset of type 1 diabetes in children: a Swedish national population-based study in 2014\u20132019. Diabet Med. 2024;41(7):e15283. https:\/\/doi.org\/10.1111\/dme.15283.","journal-title":"Diabet Med"},{"issue":"1","key":"2161_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ecl.2019.10.004","volume":"49","author":"JL Papadakis","year":"2020","unstructured":"Papadakis JL, Anderson LM, Garza K, et al. Psychosocial aspects of diabetes technology use. Endocrinol Metab Clinics of North Am. 2020;49(1):127\u201341. https:\/\/doi.org\/10.1016\/j.ecl.2019.10.004.","journal-title":"Endocrinol And Metab Clinics Of North Am"},{"issue":"1","key":"2161_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12902-023-01316-3","volume":"23","author":"de Vries Sag","year":"2023","unstructured":"de Vries Sag, Bak JCG, Verheugt CL, et al. Healthcare expenditure and technology use in pediatric diabetes care. BMC Endocr Disord. 2023;23(1):72. https:\/\/doi.org\/10.1186\/s12902-023-01316-3.","journal-title":"BMC Endocr Disord"},{"issue":"5","key":"2161_CR23","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.amjms.2019.08.008","volume":"358","author":"ND Sora","year":"2019","unstructured":"Sora ND, Shashpal F, Bond EA, Jenkins AJ. Insulin pumps: review of technological advancement in diabetes management. Am J Med Sci. 2019;358(5):326\u201331. https:\/\/doi.org\/10.1016\/j.amjms.2019.08.008.","journal-title":"Am J Med Sci"},{"issue":"2","key":"2161_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/dia.2022.0340","volume":"25","author":"EM Everett","year":"2023","unstructured":"Everett EM, Wright D, Williams A, et al. A longitudinal view of disparities in insulin pump use among youth with type 1 diabetes: the SEARCH for diabetes in youth study. Diabetes Technol & Ther. 2023;25(2):131\u201339. https:\/\/doi.org\/10.1089\/dia.2022.0340.","journal-title":"Diabetes Technol & Ther"},{"key":"2161_CR25","doi-asserted-by":"publisher","unstructured":"M AB, Nk S, As B, R E. Insulin pumps in children - a systematic review. World J Clin Pediatrics. 2022;11(6). https:\/\/doi.org\/10.5409\/wjcp.v11.i6.463.","DOI":"10.5409\/wjcp.v11.i6.463"},{"key":"2161_CR26","doi-asserted-by":"publisher","first-page":"j1285","DOI":"10.1136\/bmj.j1285","volume":"356","author":"REPOSE Study Group","year":"2017","unstructured":"REPOSE Study Group. Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE). BMJ. 2017;356:j1285. https:\/\/doi.org\/10.1136\/bmj.j1285.","journal-title":"BMJ"},{"issue":"1","key":"2161_CR27","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1097\/MJT.0000000000001097","volume":"27","author":"R Nimri","year":"2020","unstructured":"Nimri R, Nir J, Phillip M. Insulin pump therapy. Am J Ther. 2020;27(1):e30\u201341. https:\/\/doi.org\/10.1097\/MJT.0000000000001097.","journal-title":"Am J Ther"},{"key":"2161_CR28","doi-asserted-by":"publisher","unstructured":"Blackman SM, Raghinaru D, Adi S, et al. Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy. Pediatr Diabetes. 2014;15(8):564\u201372. https:\/\/doi.org\/10.1111\/pedi.12121.","DOI":"10.1111\/pedi.12121"},{"issue":"14","key":"2161_CR29","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1001\/jama.2017.13994","volume":"318","author":"B Karges","year":"2017","unstructured":"Karges B, Schwandt A, Heidtmann B, et al. Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes. JAMA. 2017;318(14):1358\u201366. https:\/\/doi.org\/10.1001\/jama.2017.13994.","journal-title":"JAMA"},{"issue":"4","key":"2161_CR30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2337\/dc18-1850","volume":"42","author":"E Toresson Grip","year":"2019","unstructured":"Toresson Grip E, Svensson AM, Miftaraj M, et al. Real-world costs of continuous insulin pump therapy and multiple daily injections for type 1 diabetes: a population-based and propensity-matched cohort from the Swedish national diabetes register. Diabetes Care. 2019;42(4):545\u201352. https:\/\/doi.org\/10.2337\/dc18-1850.","journal-title":"Diabetes Care"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-02161-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02161-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02161-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:05:36Z","timestamp":1781629536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-025-02161-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2161"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-02161-2","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"24 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Washington University\u2019s Human Research Protection Office Committee and was conducted in accordance with the declaration of Helsinki. Informed consent for participation in this study was waived by the Washington University in St. Louis Institutional Review Board (IRB), according to the IRB approval dated 11\/02\/23 (Exempt). The waiver was granted based on section 164.512 (i) of the HIPAA Privacy Rule, ensuring minimal risk to participants\u2019 privacy and including plans to protect and destroy identifiers. Given this exemption, informed consent to participate was not obtained from participants, or parents or legal guardians for any participant under the age of 16. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Datasets analyzed during this study are not publicly available for privacy reasons. Requests for de-identified data can be made by contacting the corresponding author (AMA).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}